245 related articles for article (PubMed ID: 11298340)
1. B cells activated via CD40 and IL-4 undergo a division burst but require continued stimulation to maintain division, survival and differentiation.
Rush JS; Hodgkin PD
Eur J Immunol; 2001 Apr; 31(4):1150-9. PubMed ID: 11298340
[TBL] [Abstract][Full Text] [Related]
2. Cross-linking surface Ig delays CD40 ligand- and IL-4-induced B cell Ig class switching and reveals evidence for independent regulation of B cell proliferation and differentiation.
Rush JS; Hasbold J; Hodgkin PD
J Immunol; 2002 Mar; 168(6):2676-82. PubMed ID: 11884432
[TBL] [Abstract][Full Text] [Related]
3. Integrating signals from IFN-gamma and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a.
Hasbold J; Hong JS; Kehry MR; Hodgkin PD
J Immunol; 1999 Oct; 163(8):4175-81. PubMed ID: 10510353
[TBL] [Abstract][Full Text] [Related]
4. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
Johnson-Léger C; Christensen J; Klaus GG
Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
[TBL] [Abstract][Full Text] [Related]
5. Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand.
Brines RD; Klaus GG
Int Immunol; 1993 Nov; 5(11):1445-50. PubMed ID: 7505108
[TBL] [Abstract][Full Text] [Related]
6. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
7. Arginine methylation regulates antibody responses through modulating cell division and isotype switching in B cells.
Hata K; Mizuguchi J
Microbiol Immunol; 2013 Mar; 57(3):185-92. PubMed ID: 23278594
[TBL] [Abstract][Full Text] [Related]
8. Murine B1 B cells require IL-5 for optimal T cell-dependent activation.
Erickson LD; Foy TM; Waldschmidt TJ
J Immunol; 2001 Feb; 166(3):1531-9. PubMed ID: 11160193
[TBL] [Abstract][Full Text] [Related]
9. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
[TBL] [Abstract][Full Text] [Related]
10. Interaction of B cells with activated T cells reduces the threshold for CD40-mediated B cell activation.
Klaus GG; Holman M; Johnson-Léger C; Christenson JR; Kehry MR
Int Immunol; 1999 Jan; 11(1):71-9. PubMed ID: 10050675
[TBL] [Abstract][Full Text] [Related]
11. CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production.
Lu P; Urban JF; Zhou XD; Chen SJ; Madden K; Moorman M; Nguyen H; Morris SC; Finkelman FD; Gause WC
J Immunol; 1996 May; 156(9):3327-33. PubMed ID: 8617957
[TBL] [Abstract][Full Text] [Related]
12. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
[TBL] [Abstract][Full Text] [Related]
13. Effect of B-cell receptor engagement on CD40-stimulated B cells.
Schilizzi BM; Boonstra R; The TH; de Leij LF
Immunology; 1997 Nov; 92(3):346-53. PubMed ID: 9486107
[TBL] [Abstract][Full Text] [Related]
14. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2.
Fayette J; Dubois B; Vandenabeele S; Bridon JM; Vanbervliet B; Durand I; Banchereau J; Caux C; Brière F
J Exp Med; 1997 Jun; 185(11):1909-18. PubMed ID: 9166420
[TBL] [Abstract][Full Text] [Related]
15. Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells.
Akdis CA; Blesken T; Akdis M; Alkan SS; Wüthrich B; Heusser CH; Blaser K
J Allergy Clin Immunol; 1997 Mar; 99(3):345-53. PubMed ID: 9058690
[TBL] [Abstract][Full Text] [Related]
16. Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching.
Knödel M; Kuss AW; Berberich I; Schimpl A
Eur J Immunol; 2001 Jul; 31(7):1972-80. PubMed ID: 11449349
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory role of CD40 in human B cell differentiation.
Splawski JB; Fu SM; Lipsky PE
J Immunol; 1993 Feb; 150(4):1276-85. PubMed ID: 7679424
[TBL] [Abstract][Full Text] [Related]
18. Ligation of CD40 with soluble CD40 ligand reverses anti-immunoglobulin-mediated negative signalling in murine B lymphoma cell lines but not in immature B cells from neonatal mice.
Marshall-Clarke S; Owen G; Tasker L
Immunology; 1996 Apr; 87(4):624-32. PubMed ID: 8675219
[TBL] [Abstract][Full Text] [Related]
19. CD40 cross-linking inhibits specific antibody production by human B cells.
Callard RE; Herbert J; Smith SH; Armitage RJ; Costelloe KE
Int Immunol; 1995 Nov; 7(11):1809-15. PubMed ID: 8580079
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
Li Q; Grover AC; Donald EJ; Carr A; Yu J; Whitfield J; Nelson M; Takeshita N; Chang AE
J Immunol; 2005 Aug; 175(3):1424-32. PubMed ID: 16034078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
